Literature DB >> 773578

Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.

A R Rabson, H J Koornhof.   

Abstract

Supernatants from human mononuclear cells cultured with PHA inhibited the migration of both human polymorphonuclear leucocytes and guinea-pig peritoneal exudate cells, but not human mononuclear cells. Using ultrafiltration it was shown that these supernatants contained two inhibiting factors, the one with a molecular weight of 15,000-50,000 inhibited only guinea-pig peritoneal exudate cells (MIF), whereas the fraction containing molecules of a size between 50,000 and 75,000 specifically inhibited the migration of polymorphonuclear leucocytes (LIF). The polymorphonuclear leucocyte inhibiting activity was heat labile. It is suggested that the leucocyte migration inhibition test is dependent upon the production of a lymphokine (LIF) which acts specifically on polymorphonuclear leucocytes causing their inhibition of migration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 773578      PMCID: PMC1538432     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Leukocyte migration in vitro and its relationship to human renal allograft rejection and enhancement.

Authors:  R E Falk; R D Guttmann; J G Beaudoin; D D Morehouse; J H Oh
Journal:  Transplantation       Date:  1972-05       Impact factor: 4.939

2.  In vitro study of cellular immunity against autochthonous human cancer.

Authors:  A Segall; O Weiler; J Genin; J Lacour; F Lacour
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

3.  Effect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cell-mediated immunity.

Authors:  W L Morison
Journal:  J Clin Pathol       Date:  1974-02       Impact factor: 3.411

4.  In vitro detection of transplantation immunity: the inhibition of migration of immune spleen cells and peripheral blood leukocytes by specific antigen.

Authors:  R E Falk; L Collste; G Möller
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

5.  Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.

Authors:  J E Clausen
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

6.  The production of migration inhibitory factor by nonimmune guinea pig lymphoid cells incubated with concanavalin A.

Authors:  R Pelley; H J Schwartz
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

7.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02

8.  Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.

Authors:  R E Rocklin; H G Remold; J R David
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

9.  In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test.

Authors:  G Senyk; W K Hadley
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

10.  Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration.

Authors:  D M Bull; J R Leibach; M A Williams; R A Helms
Journal:  Science       Date:  1973-09-07       Impact factor: 47.728

View more
  6 in total

1.  Migration inhibition of T lymphocytes from human peripheral blood by specific antigen and lymphokines.

Authors:  D Kowalczyk; M Zembala
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

2.  Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.

Authors:  A J Górski; B Dupont; J A Hansen; R O'Reilly; E Smithwick; R Górska; R A Good
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

3.  Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA rosette formation.

Authors:  M Kubota; T Yoshida; K Shinomiya; H Mikawa
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

4.  The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.

Authors:  R Lomnitzer; A Glover; A R Rabson
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

5.  The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.

Authors:  R Lomnitzer; A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

6.  Leucocyte capillary migration: an adherence dependent phenomenon.

Authors:  R Lomnitzer; A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.